Ava Amini explores the role of AI in precision medicine, with a focus on personalized cancer treatments. By leveraging AI to analyze broad biological data sets, researchers aim to tailor therapies to individual patients based on their specific needs. Innovative methods like EvoDiff offer promising alternatives to the current population-based approaches, and open doors to advance precision oncology.

See more at https://www.microsoft.com/en-us/resea...